Arrowhead Pharmaceuticals, Inc. (ARWR) News
Arrowhead Pharmaceuticals, Inc. (ARWR)
Today's Latest Price: $33.31 USD
Updated Jun 1 6:55pm
Add ARWR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
Filter ARWR News Items
ARWR News Results
| Event/Time | Symbol | Company | News Detail | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest ARWR News From Around the Web
Below are the latest news stories about Arrowhead Pharmaceuticals Inc that investors may wish to consider to help them evaluate ARWR as an investment opportunity.
Arrowhead Pharmaceuticals to Participate in Upcoming June 2020 ConferencesPASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals will present at Jefferies and Goldman Sachs healthcare conferences in June 2020 |
Is Arrowhead Pharmaceuticals a Buy?The development-stage genetic medicine company is eager to convert its intriguing potential into tangible progress. |
Arrowhead Pharmaceuticals Is Likely to See a Trading Range Market AheadI would look for further sideways trading on ARWR….ARWR |
Will Arrowhead Pharmaceuticals Be a Biotech Winner?A leading company in the field of gene silencing is on track to develop several breakthrough therapies. |
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This YearInvestors in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) had a good week, as its shares rose 4.9% to close at... |
Edited Transcript of ARWR earnings conference call or presentation 7-May-20 8:30pm GMTQ2 2020 Arrowhead Pharmaceuticals Inc Earnings Call |
Arrowhead Pharmaceuticals, Inc (ARWR) Q2 2020 Earnings Call TranscriptThank you for joining us today to discuss Arrowhead's results for its fiscal second quarter ended March 31, 2020. With us today from management are President and CEO, Dr. Christopher Anzalone, who will provide an overview of the quarter; Dr. Javier San Martin, Chief Medical Officer who will discuss our clinical programs; Dr. Curt Bradshaw, our Chief Scientific Officer who will discuss our discovery, platform development and manufacturing efforts; and Ken Myszkowski, our Chief Financial Officer, who will give a review of the financials. |
Arrowhead Pharmaceuticals, Inc (ARWR) Q2 2020 Earnings Call Transcript | The Motley FoolARWR earnings call for the period ending March 31, 2020. |
Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter ResultsPASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals reports fiscal Q2 2020 earnings |
Arrowhead Pharmaceuticals to Participate in Upcoming May 2020 ConferencesPASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead will present at upcoming May 2020 investor conferences |
